EMEA (Europe, Middle East and Africa) OTC Drug Market Report 2017

December 2017 | 113 pages | ID: E9B95445DCAEN
QYResearch

Abstracts

In this report, the EMEA OTC Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of OTC Drug for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA OTC Drug market competition by top manufacturers/players, with OTC Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bayer HealthCare
• GlaxoSmithKline (GSK)
• Johnson&Johnson
• Pfizer
• Sanofi
• AstraZeneca
• BioGaia
• Bristol Myers Squibb
• Bukwang Pharmaceutica
• Chr. Hansen
• Cipla
• CoLucid
• Daiichi Sankyo
• Friggs
• DSM
• Eisai
• Eli Lilly
• Herbalife
• Euradite

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Class A
• Class B

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Household

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) OTC Drug Market Report 2017

1 OTC DRUG OVERVIEW

1.1 Product Overview and Scope of OTC Drug
1.2 Classification of OTC Drug
  1.2.1 EMEA OTC Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA OTC Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Class A
  1.2.4 Class B
1.3 EMEA OTC Drug Market by Application/End Users
  1.3.1 EMEA OTC Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Household
1.4 EMEA OTC Drug Market by Region
  1.4.1 EMEA OTC Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of OTC Drug (2012-2022)
  1.5.1 EMEA OTC Drug Sales and Growth Rate (2012-2022)
  1.5.2 EMEA OTC Drug Revenue and Growth Rate (2012-2022)

2 EMEA OTC DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA OTC Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA OTC Drug Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA OTC Drug Revenue and Share by Players (2012-2017)
  2.1.3 EMEA OTC Drug Sale Price by Players (2012-2017)
2.2 EMEA OTC Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA OTC Drug Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA OTC Drug Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA OTC Drug Sale Price by Type (2012-2017)
2.3 EMEA OTC Drug (Volume) by Application
2.4 EMEA OTC Drug (Volume and Value) by Region
  2.4.1 EMEA OTC Drug Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA OTC Drug Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA OTC Drug Sales Price by Region (2012-2017)

3 EUROPE OTC DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe OTC Drug Sales and Value (2012-2017)
  3.1.1 Europe OTC Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe OTC Drug Revenue and Growth Rate (2012-2017)
3.2 Europe OTC Drug Sales and Market Share by Type
3.3 Europe OTC Drug Sales and Market Share by Application
3.4 Europe OTC Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe OTC Drug Sales Volume by Countries (2012-2017)
  3.4.2 Europe OTC Drug Revenue by Countries (2012-2017)
  3.4.3 Germany OTC Drug Sales and Growth Rate (2012-2017)
  3.4.4 France OTC Drug Sales and Growth Rate (2012-2017)
  3.4.5 UK OTC Drug Sales and Growth Rate (2012-2017)
  3.4.6 Russia OTC Drug Sales and Growth Rate (2012-2017)
  3.4.7 Italy OTC Drug Sales and Growth Rate (2012-2017)
  3.4.8 Benelux OTC Drug Sales and Growth Rate (2012-2017)

4 MIDDLE EAST OTC DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East OTC Drug Sales and Value (2012-2017)
  4.1.1 Middle East OTC Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East OTC Drug Revenue and Growth Rate (2012-2017)
4.2 Middle East OTC Drug Sales and Market Share by Type
4.3 Middle East OTC Drug Sales and Market Share by Application
4.4 Middle East OTC Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East OTC Drug Sales Volume by Countries (2012-2017)
  4.4.2 Middle East OTC Drug Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia OTC Drug Sales and Growth Rate (2012-2017)
  4.4.4 Israel OTC Drug Sales and Growth Rate (2012-2017)
  4.4.5 UAE OTC Drug Sales and Growth Rate (2012-2017)
  4.4.6 Iran OTC Drug Sales and Growth Rate (2012-2017)

5 AFRICA OTC DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa OTC Drug Sales and Value (2012-2017)
  5.1.1 Africa OTC Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa OTC Drug Revenue and Growth Rate (2012-2017)
5.2 Africa OTC Drug Sales and Market Share by Type
5.3 Africa OTC Drug Sales and Market Share by Application
5.4 Africa OTC Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa OTC Drug Sales Volume by Countries (2012-2017)
  5.4.2 Africa OTC Drug Revenue by Countries (2012-2017)
  5.4.3 South Africa OTC Drug Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria OTC Drug Sales and Growth Rate (2012-2017)
  5.4.5 Egypt OTC Drug Sales and Growth Rate (2012-2017)
  5.4.6 Algeria OTC Drug Sales and Growth Rate (2012-2017)

6 EMEA OTC DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Bayer HealthCare
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 OTC Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline (GSK)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 OTC Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Johnson&Johnson
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 OTC Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Johnson&Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 OTC Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 OTC Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AstraZeneca
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 OTC Drug Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 BioGaia
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 OTC Drug Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bristol Myers Squibb
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 OTC Drug Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Bukwang Pharmaceutica
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 OTC Drug Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Chr. Hansen
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 OTC Drug Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Cipla
6.12 CoLucid
6.13 Daiichi Sankyo
6.14 Friggs
6.15 DSM
6.16 Eisai
6.17 Eli Lilly
6.18 Herbalife
6.19 Euradite

7 OTC DRUG MANUFACTURING COST ANALYSIS

7.1 OTC Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of OTC Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 OTC Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of OTC Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA OTC DRUG MARKET FORECAST (2017-2022)

11.1 EMEA OTC Drug Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA OTC Drug Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA OTC Drug Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA OTC Drug Price and Trend Forecast (2017-2022)
11.2 EMEA OTC Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe OTC Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt OTC Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa OTC Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA OTC Drug Sales Forecast by Type (2017-2022)
11.7 EMEA OTC Drug Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of OTC Drug
Figure EMEA OTC Drug Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA OTC Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Class A Product Picture
Figure Class B Product Picture
Figure EMEA OTC Drug Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of OTC Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Household Examples
Table Key Downstream Customer in Household
Figure EMEA OTC Drug Market Size (Million USD) by Region (2012-2022)
Figure Europe OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe OTC Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East OTC Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa OTC Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA OTC Drug Sales Volume and Growth Rate (2012-2022)
Figure EMEA OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA OTC Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA OTC Drug Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA OTC Drug Sales Share by Players (2012-2017)
Figure 2016 OTC Drug Sales Share by Players
Figure 2017 OTC Drug Sales Share by Players
Figure EMEA OTC Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA OTC Drug Revenue (Million USD) by Players (2012-2017)
Table EMEA OTC Drug Revenue Share by Players (2012-2017)
Table 2016 EMEA OTC Drug Revenue Share by Players
Table 2017 EMEA OTC Drug Revenue Share by Players
Table EMEA OTC Drug Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA OTC Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA OTC Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of OTC Drug by Type (2012-2017)
Figure EMEA OTC Drug Sales Market Share by Type (2012-2017)
Table EMEA OTC Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA OTC Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of OTC Drug by Type in 2016
Table EMEA OTC Drug Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA OTC Drug Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA OTC Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of OTC Drug by Application (2012-2017)
Figure EMEA OTC Drug Sales Market Share by Application in 2016
Table EMEA OTC Drug Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA OTC Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of OTC Drug by Region (2012-2017)
Figure EMEA OTC Drug Sales Market Share in 2016
Table EMEA OTC Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA OTC Drug Revenue Share by Region (2012-2017)
Figure Revenue Market Share of OTC Drug by Region (2012-2017)
Figure EMEA OTC Drug Revenue Market Share Regions in 2016
Table EMEA OTC Drug Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe OTC Drug Revenue and Growth Rate (2012-2017)
Table Europe OTC Drug Sales (K Pcs) by Type (2012-2017)
Table Europe OTC Drug Market Share by Type (2012-2017)
Figure Europe OTC Drug Market Share by Type in 2016
Table Europe OTC Drug Sales (K Pcs) by Application (2012-2017)
Table Europe OTC Drug Market Share by Application (2012-2017)
Figure Europe OTC Drug Market Share by Application in 2016
Table Europe OTC Drug Sales (K Pcs) by Countries (2012-2017)
Table Europe OTC Drug Sales Market Share by Countries (2012-2017)
Figure Europe OTC Drug Sales Market Share by Countries (2012-2017)
Figure Europe OTC Drug Sales Market Share by Countries in 2016
Table Europe OTC Drug Revenue (Million USD) by Countries (2012-2017)
Table Europe OTC Drug Revenue Market Share by Countries (2012-2017)
Figure Europe OTC Drug Revenue Market Share by Countries (2012-2017)
Figure Europe OTC Drug Revenue Market Share by Countries in 2016
Figure Germany OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure France OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East OTC Drug Sales (K Pcs) by Type (2012-2017)
Table Middle East OTC Drug Market Share by Type (2012-2017)
Figure Middle East OTC Drug Market Share by Type (2012-2017)
Table Middle East OTC Drug Sales (K Pcs) by Applications (2012-2017)
Table Middle East OTC Drug Market Share by Applications (2012-2017)
Figure Middle East OTC Drug Sales Market Share by Application in 2016
Table Middle East OTC Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East OTC Drug Sales Volume Market Share by Countries (2012-2017)
Figure Middle East OTC Drug Sales Volume Market Share by Countries in 2016
Table Middle East OTC Drug Revenue (Million USD) by Countries (2012-2017)
Table Middle East OTC Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East OTC Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East OTC Drug Revenue Market Share by Countries in 2016
Figure Saudi Arabia OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa OTC Drug Sales (K Pcs) by Type (2012-2017)
Table Africa OTC Drug Sales Market Share by Type (2012-2017)
Figure Africa OTC Drug Sales Market Share by Type (2012-2017)
Figure Africa OTC Drug Sales Market Share by Type in 2016
Table Africa OTC Drug Sales (K Pcs) by Application (2012-2017)
Table Africa OTC Drug Sales Market Share by Application (2012-2017)
Figure Africa OTC Drug Sales Market Share by Application (2012-2017)
Table Africa OTC Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa OTC Drug Sales Market Share by Countries (2012-2017)
Figure Africa OTC Drug Sales Market Share by Countries (2012-2017)
Figure Africa OTC Drug Sales Market Share by Countries in 2016
Table Africa OTC Drug Revenue (Million USD) by Countries (2012-2017)
Table Africa OTC Drug Revenue Market Share by Countries (2012-2017)
Figure Africa OTC Drug Revenue Market Share by Countries (2012-2017)
Figure Africa OTC Drug Revenue Market Share by Countries in 2016
Figure South Africa OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Table Bayer HealthCare OTC Drug Basic Information List
Table Bayer HealthCare OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer HealthCare OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bayer HealthCare OTC Drug Sales Market Share in EMEA (2012-2017)
Figure Bayer HealthCare OTC Drug Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline (GSK) OTC Drug Basic Information List
Table GlaxoSmithKline (GSK) OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline (GSK) OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline (GSK) OTC Drug Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline (GSK) OTC Drug Revenue Market Share in EMEA (2012-2017)
Table Johnson&Johnson OTC Drug Basic Information List
Table Johnson&Johnson OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson&Johnson OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Johnson&Johnson OTC Drug Sales Market Share in EMEA (2012-2017)
Figure Johnson&Johnson OTC Drug Revenue Market Share in EMEA (2012-2017)
Table Pfizer OTC Drug Basic Information List
Table Pfizer OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer OTC Drug Sales Market Share in EMEA (2012-2017)
Figure Pfizer OTC Drug Revenue Market Share in EMEA (2012-2017)
Table Sanofi OTC Drug Basic Information List
Table Sanofi OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sanofi OTC Drug Sales Market Share in EMEA (2012-2017)
Figure Sanofi OTC Drug Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca OTC Drug Basic Information List
Table AstraZeneca OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure AstraZeneca OTC Drug Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca OTC Drug Revenue Market Share in EMEA (2012-2017)
Table BioGaia OTC Drug Basic Information List
Table BioGaia OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BioGaia OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure BioGaia OTC Drug Sales Market Share in EMEA (2012-2017)
Figure BioGaia OTC Drug Revenue Market Share in EMEA (2012-2017)
Table Bristol Myers Squibb OTC Drug Basic Information List
Table Bristol Myers Squibb OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol Myers Squibb OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bristol Myers Squibb OTC Drug Sales Market Share in EMEA (2012-2017)
Figure Bristol Myers Squibb OTC Drug Revenue Market Share in EMEA (2012-2017)
Table Bukwang Pharmaceutica OTC Drug Basic Information List
Table Bukwang Pharmaceutica OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bukwang Pharmaceutica OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bukwang Pharmaceutica OTC Drug Sales Market Share in EMEA (2012-2017)
Figure Bukwang Pharmaceutica OTC Drug Revenue Market Share in EMEA (2012-2017)
Table Chr. Hansen OTC Drug Basic Information List
Table Chr. Hansen OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Chr. Hansen OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Chr. Hansen OTC Drug Sales Market Share in EMEA (2012-2017)
Figure Chr. Hansen OTC Drug Revenue Market Share in EMEA (2012-2017)
Table Cipla OTC Drug Basic Information List
Table CoLucid OTC Drug Basic Information List
Table Daiichi Sankyo OTC Drug Basic Information List
Table Friggs OTC Drug Basic Information List
Table DSM OTC Drug Basic Information List
Table Eisai OTC Drug Basic Information List
Table Eli Lilly OTC Drug Basic Information List
Table Herbalife OTC Drug Basic Information List
Table Euradite OTC Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of OTC Drug
Figure Manufacturing Process Analysis of OTC Drug
Figure OTC Drug Industrial Chain Analysis
Table Raw Materials Sources of OTC Drug Major Manufacturers in 2016
Table Major Buyers of OTC Drug
Table Distributors/Traders List
Figure EMEA OTC Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA OTC Drug Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA OTC Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA OTC Drug Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA OTC Drug Sales Market Share Forecast by Region (2017-2022)
Table EMEA OTC Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA OTC Drug Revenue Market Share Forecast by Region (2017-2022)
Table Europe OTC Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe OTC Drug Sales Market Share Forecast by Countries (2017-2022)
Table Europe OTC Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe OTC Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East OTC Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East OTC Drug Sales Market Share Forecast by Countries (2017-2022)
Table Middle East OTC Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East OTC Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Africa OTC Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa OTC Drug Sales Market Share Forecast by Countries (2017-2022)
Table Africa OTC Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa OTC Drug Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA OTC Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA OTC Drug Sales Market Share Forecast by Type (2017-2022)
Table EMEA OTC Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA OTC Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources